Syngene symptoms 10-12 months settlement with Zoetis

Syngene symptoms 10-12 months settlement with Zoetis

by admin- Friday, July 15th, 2022 03:43:22 PM

Syngene International signed 10-year settlement with main animal health company, Zoetis, to manufacture the drug substance for Librela (bedinvetmab), a primary in class monoclonal antibody used for treating osteoarthritis in dogs. Launched in Europe, the UK and Switzerland, the product won ‘Best
new associate animal product’ by means of IHS Markit Connect in 2021 for its transformational effect on pain remedy for canine affected by this debilitating condition.

News Updates